Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0001415889-25-012679

CHIEF FINANCIAL OFFICER acquired 74,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coveney Kevin Michael CHIEF FINANCIAL OFFICER 2025-05-08 Grant or award +74,150 86,584 D
Loading xslF345X05/form4-05122025_050505.xml…